Renal hybrid oncocytic/chromophobe tumour
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Renal hybrid oncocytic/chromophobe tumour | |
---|---|
Diagnosis in short | |
Hybrid oncocytic/chromophobe tumour of the kidney. H&E stain. | |
| |
Synonyms | hybrid tumour |
| |
LM | features of renal oncocytoma and chromophobe renal cell carcinoma - varies by subtype |
Subtypes | as per Hes et al.: (1) collision tumour-type, (2) renal oncocytoma with scattered chromophobe cells-type, (3) large eosinophilic cells with intracytoplasmic vacuoles-type |
LM DDx | renal oncocytoma, chromophobe renal cell carcinoma, renal cell carcinoma, unclassified, SDH-deficient renal cell carcinoma, other renal tumours with eosinophilic cytoplasm |
Stains | Hale's colloidal iron +ve |
IHC | CD117 +ve, CK7 +ve (variable) |
Molecular | no features of ChRCC |
Grossing notes | partial nephrectomy grossing, total nephrectomy for tumour grossing |
Site | kidney - see kidney tumours |
| |
Syndromes | Birt–Hogg–Dubé syndrome |
| |
Clinical history | renal mass |
Prevalence | very rare |
Prognosis | good on very limited data |
Treatment | surgical excision |
Renal hybrid oncocytic/chromophobe tumour, also hybrid oncocytic/chromophobe tumour (abbreviated HOCT) and hybrid tumour, is a rare kidney tumour with features of chromophobe renal cell carcinoma and renal oncocytoma.[1]
General
- Rare.
- Molecular heterogeneous group[1] - may represent several different entities.
- Prognosis good - based on one series of 11 cases.[2]
May be seen in several contexts:[1]
- Sporadic.
- Birt–Hogg–Dubé syndrome.
- Renal oncocytosis.
Microscopic
Three morphologic patterns as per Hes et al.:[1]
- Renal oncocytoma and chromophobe renal cell carcinoma collision tumour.
- Different fields viewed in isolation would be compatible with the different diagnoses. Tumour component do not intermingle.
- Renal oncocytoma with scattered chromophobe cells.
- Large eosinophilic cell with intracytoplasmic vacuoles - this is the evolving entity eosinophilic vacuolated tumour.
- Prominent nucleoli (ISUP nucleolar grade 3).
- Perinuclear halos (occasional).
- Nested architecture.
DDx:
- Renal oncocytoma - may have limited chromophobe-like areas (<=5% of tumour).[3]
- Chromophobe renal cell carcinoma, eosinophilic variant.
- SDH-deficient renal cell carcinoma - lower nuclear grade, not nested.
- Eosinophilic vacuolated tumour - evolving entity.
- Other renal tumours with eosinophilic cytoplasm.
- Renal cell carcinoma, unclassified.
Images
Case 1
Case 2
Stains
Features:[2]
- Hale's colloidal iron +ve (apical pattern).
IHC
Features:
Others:
- Vimentin -ve.
- EMA +ve.
- CD10 +ve.
- PAX8 +ve.
Molecular
- No features characteristic of chromophobe RCC on array-CGH analysis.[2]
Sign out
Left Kidney, Partial Nephrectomy: - Renal tumour with eosinophilic cytoplasm of undetermined malignant potential in keeping with the so called "hybrid oncocytic/chromophobe tumour", see comment. -- Resection margins clear. -- Tumour limited to kidney. Comment: The tumour may be seen in the context of Birt–Hogg–Dubé syndrome.
See also
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Hes, O.; Petersson, F.; Kuroda, N.; Hora, M.; Michal, M. (Oct 2013). "Renal hybrid oncocytic/chromophobe tumors - a review.". Histol Histopathol 28 (10): 1257-64. PMID 23740406.
- ↑ 2.0 2.1 2.2 2.3 Poté, N.; Vieillefond, A.; Couturier, J.; Arrufat, S.; Metzger, I.; Delongchamps, NB.; Camparo, P.; Mège-Lechevallier, F. et al. (Jun 2013). "Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.". Virchows Arch 462 (6): 633-8. doi:10.1007/s00428-013-1422-4. PMID 23708994.
- ↑ Trpkov, K.; Yilmaz, A.; Uzer, D.; Dishongh, KM.; Quick, CM.; Bismar, TA.; Gokden, N. (Dec 2010). "Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features.". Histopathology 57 (6): 893-906. doi:10.1111/j.1365-2559.2010.03726.x. PMID 21166703.